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 30 year old woman, diagnosed case of multiple 
sclerosis on immunosuppressive therapy, 
admitted in neurology ward with acute onset 
quadriparesis with limb paresthesia without visual and 
bladder or bowel impairment. The present event was not 
exacerbated by fever or high temperature. There was no 
suggestion of concomitant infection. There was no history 
of cognitive dysfunction.  She became dependent on 
family member for routine activities. Past history revealed 
two episodes of neurological disability with full recovery 
in last one and half years.  
The neurological examination on day of admission 
revealed power of grade 4/5 in upper limbs and 3/5 in both 
lower limbs based on MRC scale. The deep tendon 
reflexes were brisk and plantars showed bilateral extensor 
response. The spasticity was evident in both upper and 
lower limbs. Magnetic Resonance imaging (MRI) brain 
showed increase in demyelinating lesion load suggested 
acute relapse phase of MS [figure1]. She was started on 
intravenous methylprednisolone therapy in a dose of 1000 
mg/day. After one day of therapy, she developed 
deterioration of weakness and became bedbound. On 
examination, she was afebrile and vitals were stable. 
Higher mental function and cranial nerve examination 
were normal. Motor system examination revealed 
hypotonia in all four limbs with sluggish deep tendon 
reflexes. Power was grade 3/5 in both upper limbs and 2/5 
in both lower limbs according to Medical research council 
(MRC) grading. Sensory examination was normal. 
Cerebellar examination was unremarkable.  
 
Figure 1: Magnetic resonance imaging brain axial T2 
flair image showing multiple white matter hyper 
intensities involving periventricular and subcortical 
area suggestive of demyelination 
Routine investigations like hemogram, blood sugar, 
renal and liver function test were normal except serum 
potassium level was found to be low (2.2mmol/L). Thyroid 
hormone level including thyroid peroxidase and 
thyroglobulin antibodies were normal. Creatine 
phosphokinase (CPK) level and nerve conduction study 
were normal. Patient was supplemented with oral 
potassium chloride. Next day, she showed improvement in 
limb weakness with return of normal tone. Repeat serum 
potassium level was within normal range (4.5 mmol/L). 
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Multiple sclerosis is demyelinating disease of central 
nervous system and usually presents as a relapsing-
remitting course and many atypical forms. Generally acute 
relapse of multiple sclerosis presents with occurrence of 
new or worsening of existing neurological deficit [1]. High 
dose methylprednisolone therapy is recommended during 
acute relapse of multiple sclerosis. Development of 
hypokalemia leading to worsening of weakness and 
hypotonia is a potential early complication of 
methylprednisolone therapy. Possible hypothesis being 
increased Na/K-ATPase pump activity causing a rapid 
shift of potassium from the extracellular into the 
intracellular compartment [2, 3].   
Differential diagnosis of flaccid paralysis in such cases 
should be considered are thyrotoxic periodic paralysis [4], 
steroid induced myopathy, acute inflammatory 
polyneuropathy. Thyrotoxic periodic paralysis can rarely 
present as acute muscle paralysis and prevalence is more 
common in Asian males. The triggering factors for 
thyrotoxic periodic paralysis include high carbohydrate 
diet, strenuous exercise and steroid therapy. Our patient 
had no evidence of thyrotoxicosis [5]. So while treating the 
acute relapse of multiple sclerosis, primary physician 
should be aware of hypokalemia as a potential 
complication of high dose corticosteroid therapy and 
hypokalemic paralysis should be considered if flaccid 
weakness develops during the corticosteroid therapy. 
Immediate potassium replacement is required to improve 
 
 
 
 
 
 
 
 
 
 
the motor weakness.    
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